The Value of Magnetic Resonance Imaging for Assessing Disease Extent and Prediction of Relapse in Early Peripheral Spondyloarthritis
- 13 May 2021
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 73 (11) , 2044-2051
Abstract
Objective: This study was undertaken to assess the inflammatory burden in peripheral spondyloarthritis (SpA) by magnetic resonance imaging (MRI) of the legs in an early remission–induction strategy study of tumor necrosis factor (TNF) blockade. Furthermore, we sought to determine the value of MRI to predict disease relapse versus sustained remission after treatment discontinuation.Methods: Thirty‐two patients with early peripheral SpA with involvement of the legs determined on clinical examination and confirmed by ultrasonography (US) participated in a remission‐induction trial of a TNF inhibitor (TNFi). Patients underwent MRI of the joints and entheses of the legs at baseline and at clinical remission, after which TNFi treatment was withdrawn. Images were evaluated for joint effusion, joint osteitis, entheseal soft tissue inflammation, and entheseal osteitis.Results: Joint effusion and enthesitis on clinical examination and US correlated well with MRI abnormalities. In addition, a substantial amount of subclinical involvement was seen on MRI, mainly in the ankle joints and heel entheses. Inflammation scores were markedly lower in the subclinically involved joints and entheses versus those that were clinically involved (P values ranged from 0.01 to P < 0.001). Whereas 80% of the joints that were clinically involved at baseline showed no effusion on remission MRI, 2 of 3 entheses involved at baseline showed residual inflammation. In addition, patients who experienced a relapse after treatment discontinuation displayed more entheseal soft tissue inflammation on remission MRI compared to those who maintained drug‐free remission (P = 0.028).Conclusion: Our findings delineate a differential response of synovitis and enthesitis, with enthesitis on MRI being less responsive to TNFi treatment. Furthermore, residual entheseal inflammation might be indicative of the need for continuous therapy.Keywords
Funding Information
- Janssen Pharmaceutica
This publication has 29 references indexed in Scilit:
- Entheseal Power Doppler Ultrasonography: A Comparison of Psoriatic Arthritis and FibromyalgiaThe Journal of Rheumatology, 2012
- Is there subclinical enthesitis in early psoriatic arthritis? A clinical comparison with power doppler ultrasoundArthritis Care & Research, 2012
- Role of whole-body magnetic resonance imaging in diagnosing early spondyloarthritisEuropean Journal of Radiology, 2009
- MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)Annals of the Rheumatic Diseases, 2009
- Distinct topography of erosion and new bone formation in achilles tendon enthesitis: Implications for understanding the link between inflammation and bone formation in spondylarthritisArthritis & Rheumatism, 2008
- Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: A cross‐sectional studyArthritis & Rheumatism, 2003
- Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathyAnnals of the Rheumatic Diseases, 2002
- Classification of inflammatory arthritis by enthesitisThe Lancet, 1998
- Studies with an enthesis index as a method of clinical assessment in ankylosing spondylitis.Annals of the Rheumatic Diseases, 1987
- Enthesopathy of rheumatoid and ankylosing spondylitis.Annals of the Rheumatic Diseases, 1971